Job description
As the Head of Finance and Commercial Operations, you will lead the Finance, Supply Chain, Compliance, SHE and Facilities functions. You are responsible for designing and executing Finance and Commercial Operations strategies, influence and advocate strategies to drive top line while maintaining profitability.In this position, you will be in a key role to help shape and enable the Roche Diagnostics Malaysia (RDMY) strategy, and contribute to the overall Roche Diagnostics vision.You demonstrate personal purpose around improving the healthcare ecosystem thinking from an enterprise level, beyond boundaries and borders, to bring the best possible outcomes to the healthcare environment; creating better health outcomes for more patients faster, and by bringing a strong entrepreneurial mentality with outstanding partnering capabilities.
Responsibilities & skills
Education
Solid understanding of all the adjacent enabling functions beyond Finance, strong business acumen, and know how to connect the dots within the enterprise and above country. Proven analytical and forward-looking thought process, and has experience in analysing the feasibility of complex deals & partnerships, and making appropriate recommendations. Consistent track record of building collaborative relationships with peers and teams, helping cross-functional teams address strategic opportunities and challenges across the organization.
Experience
Experienced finance leader (10+ years in healthcare or diagnostics industry) with a record of accomplishment in strategy development, leadership, people management, and execution of large, complex, cross-functional (cross-enterprise) programs / initiatives.
Ready to apply?
Sign in and make sure your profile and resume are up to date.
Roche
Roche was one of the first companies to bring targeted treatments to patients. With our combined strength in pharmaceuticals and diagnostics, we are better equipped than any other company to further drive personalised healthcare. Two-thirds of our Research and Development projects are being developed with companion diagnostics.We are the world's number 1 in biotech with 17 biopharmaceuticals on the market. Over half of the compounds in our product pipeline are biopharmaceuticals, enabling us to deliver better-targeted therapies.We have been at the forefront of cancer research and treatment for over 50 years, with medicines for breast, skin, colon, ovarian, lung and numerous other cancers.We offer doctors profound information to guide treatments and to answer more patients’ questions than any other company. And our tests enable hospitals and labs to deliver that information quickly and reliably.We invest around 9 billion Swiss francs in Research and Development every year because innovation is our lifeblood. This is amongst the highest Research and Development spends in the world across all industries.
View company profile